| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 100.04% | 99.98% | 99.84% | 99.94% | 99.41% | 99.44% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | -0.04% | 0.02% | 0.16% | 0.06% | 0.59% | 0.56% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 23,332 | 4.24 | 17.01% | -1.07%↓ |
| Divis Laboratories Ltd. | Healthcare | 2,800 | 2.6 | 10.44% | 0.09%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 2,268 | 1.85 | 7.43% | -0.45%↓ |
| Laurus Labs Ltd. | Healthcare | 8,582 | 1.7 | 6.82% | 0.41%↑ |
| Cipla Ltd. | Healthcare | 12,401 | 1.67 | 6.70% | -0.12%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 13,438 | 1.66 | 6.65% | 0.60%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 3,243 | 1.56 | 6.25% | -0.14%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 16,399 | 1.52 | 6.12% | -0.55%↓ |
| Lupin Ltd. | Healthcare | 5,353 | 1.09 | 4.36% | -0.21%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 6,090 | 1.02 | 4.09% | 0.00% |
| Fortis Healthcare Ltd. | Healthcare | 11,482 | 0.88 | 3.55% | -0.52%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 3,318 | 0.77 | 3.11% | -0.10%↓ |
| Alkem Laboratories Ltd. | Healthcare | 1,329 | 0.69 | 2.75% | 0.07%↑ |
| Zydus Lifesciences Ltd. | Healthcare | 5,460 | 0.63 | 2.55% | 0.05%↑ |
| Mankind Pharma Ltd. | Healthcare | 2,497 | 0.63 | 2.51% | 0.15%↑ |
| Ipca Laboratories Ltd. | Healthcare | 3,061 | 0.59 | 2.37% | 0.01%↑ |
| Biocon Ltd. | Healthcare | 15,357 | 0.57 | 2.28% | -0.25%↓ |
| Gland Pharma Ltd. | Healthcare | 1,756 | 0.51 | 2.04% | - |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 5,880 | 0.44 | 1.76% | - |
| Abbott India Ltd. | Healthcare | 115 | 0.31 | 1.25% | 0.10%↑ |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 100.04% | 99.98% | 99.84% | 99.94% | 99.41% | 99.44% |
30.9 / 100
Weighted average Value score is 30.9. This indicates that portfolio is relatively reasonably valued using composite of value measures.
73.9 / 100
Weighted average Price Momentum score is 73.9. This indicates that portfolio has average momentum using composite of momentum measures.
86.1 / 100
Weighted average Quality score is 86.1. This indicates that portfolio has high quality using composite of quality measures.
75.5 / 100
Weighted average QVM score is 75.5. This indicates that portfolio has high QVM score and hence could be considered for investment.
